Utah is doubling down on its pioneering AI regulatory sandbox, announcing new healthcare AI pilots and a strengthened oversight framework. August AI will test AI-assisted prescription renewals for chronic conditions — including first-line treatments for diabetes and cardiovascular disease — at $4 per renewal, while Nolla Health's dermatology app will issue initial acne prescriptions for $4.99/month. Expect Fitness rounds out the new pilots with AI-enabled pelvic floor physical therapy for women. Utah-licensed physicians review every case in the early stages of each pilot.

To address mounting concerns — including pushback from the Utah Medical Licensing Board, which wasn't initially consulted on earlier pilots — the state is adding a clinical AI advisory group, a physician-led working group, and a network of independent third-party evaluators (including Stanford's Clinical Excellence Research Center and Coalition for Health AI) to stress-test guardrails, inspect decision logs, and verify developer claims.

Key Takeaways:

• Physician review is mandatory at every stage of all new pilots before any reduced-oversight prescribing is permitted
• Later pilot phases — where prescriptions could be issued with only post-hoc physician review — require written regulatory approval before activation
• Master agreements with University of Utah Health and Intermountain Health set the terms for future pilots at those systems
• Independent evaluators will assess expected benefits, failure modes, and evidence thresholds for each use case

Why it matters: Utah's sandbox is shaping up as a potential national blueprint for how states can responsibly test clinical AI — balancing innovation with patient safety, liability clarity, and real-world evidence generation. The results are expected to directly inform future legislation.